List of Devices Companies in India - 15

Since 1978, Appasamy Associates and Group of companies have been leading manufacturers and distributors of Ophthalmic Diagnostic & Surgical Equipments, Intraocular Lenses (IOLs), Microsurgical Instruments and Ophthalmic Pharmaceuticals. Our four decades of work have been widely appreciated throughout the world. Our dedication to support our products had become a bench mark among the community. We have dedicated R & D team to fulfil state of the art requirements of the ophthalmic community. We strive hard to make each and every modern technology and equipment within the easy reach of ophthalmic surgeons and visions care professionals in India. Our various manufacturing facilities at Chennai, Pondicherry and Baddi have got quality systems certifications audited by TUV, DNV and ITC for ISO 9000 and ISO 13485 requirements. The certifications bodies also provided CE marking for various products.

Biosense is among the leading Point of Care Testing and Instrumentation companies in India. Biosense Technologies is part of the Tulip Diagnostics, a Perkin Elmer Company. For more, visit our website www.biosense.in

Cardiotrack is a disruptive healthcare diagnostics solution that is making healthcare delivery more efficient. The mission of Cardiotrack is to reduce the cost of diagnosis by an order of magnitude through innovation in product design, and enhancements in healthcare workflow. Key challenges faced by healthcare providers include – the high cost of diagnostic equipment and lack of trained professionals, especially in semi-urban areas. Cardiotrack is addressing both these issues through the state of the art medical electronics, data analytics, cloud storage and diagnostics workflow management. Cardiotrack focuses on heart health and has consulted with some of the best medical research institutions in India like St John's Research Institute & Jayadeva Institute of Cardiovascular Science in Bangalore; brought onboard doctors and cardiologists as advisers and is collaborating researchers at the Loyola University of Chicago to deliver a comprehensive diagnostics solution for cardiovascular diseases (CVD). Cardiotrack is a multiple parameter handheld diagnostic device including 12-lead ECG monitor, pulse oximeter and blood pressure monitor integrated with mobile-based practice management solution and cloud backend. Low cost, portability and network-connectivity mean that Cardiotrack may be deployed at the primary care level and the resultant scan of the patient can be delivered instantaneously to a specialist anywhere in the world. This approach leads to efficient use of specialists'​ time, enables early diagnosis of heart patients and thus reduces the need for expensive invasive intervention. YouTube: https://www.youtube.com/watch?v=Tj3EI2iC7RE

Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years. Our credo and our purpose of ‘Caring for Life' continues to guide our actions towards our people and the planet for creating a sustainable future. Cipla today has presence in 80+ countries, providing over 1,500 products across various therapeutic categories in 50+ dosage forms. Keeping with our legacy of care, we constantly strive to ensure access to high-quality medicines that make a difference in the lives of patients. Our paradigm-changing offer of a triple anti-retroviral (ARV) therapy in HIV/AIDS at less than a dollar a day in Africa in 2001 was pivotal in bringing inclusiveness, accessibility and affordability to the centre of the HIV movement. An unmatched presence across the care continuum (awareness, prevention, diagnosis, treatment and adherence) and the widest range of drug-device combinations has established Cipla’s respiratory leadership in India and other key emerging markets. Armed with this legacy and a deep understanding of the lungs, we have articulated our aspiration to become a global lung leader and help millions breathe free.

Concept Medical Inc. is a Research-oriented organization. It is into the development of a novel drug-eluting balloon catheter (DEB) using the latest Nano Technology. Aim of CMI is to develop innovative and revolutionary medical devices for the treatment of Cardiovascular Diseases. Concept Medical Inc. was incorporated on June 2008 in Cleveland OH. Later on, the company moved to San Jose, California. Currently, the company has a Business Development office with its Main Research Unit located at Surat, India. Concept Medical Inc. has set up a full-fledged research center which is involved in the development of Nanocarrier based drug delivery technology. Its team of Scientists and Engineers hold International Patents on research. Concept Medical Research Pvt. Ltd. has featured on Indian Government's list of top ten companies in the Pharmaceutical sector for its research in Medical Device technology. Our core development areas and offerings include drug delivery technologies comprising of various types of coatings, nanoparticles, and nanocarrier delivery systems, and coatings that have pro healing properties, and biocompatibility capabilities. Our strategy is to build on our strong technical leadership in the field of Nano carrier-based drug delivery and products, visioning to strengthen our position as an innovative and resourceful product development partner to the Medical Device industry.

Fibroheal Woundcare Pvt Ltd is a startup approved under Startup India and Startup Karnataka and winner of National Technology Award under startup category & working on leveraging biomaterial property of silk to innovate and develop various biomedical application of silk proteins to address different healthcare needs. we are supported by by DBT, Government of India, Center for cellular and molecular platforms (CCAMP) and Department of IT,BT and ST, Govt of Karnataka. We work on Bio Modified silk proteins to develop various innovative medical devices / other products for Advanced and Active wound care management addressing non healing, slow healing and difficult to heal acute and chronic wounds. We have been recognised by BIRAC for our innovation and commercialising a patented product from Silk Protein which assists in faster healing of wounds through higher scaffold formation and tissue regeneration. We aspire to be a comprehensive Woundcare company addressing various types of wounds and make a difference with our unique meaningful science. Look forward to make a difference in woundcare space and passing on the benefits of economic multiplier potential of Silk and silk proteins to the masses while being most comprehensive woundcare company from India.

Meril's core objective is to design, manufacture and distribute clinically relevant, state-of-the-art and best-in-class medical devices to alleviate human suffering and improve quality of life. We thus have a strong commitment towards R & D and adherence to best quality standards in Manufacturing, Scientific Communication and Distribution known today. Origin Established in 2006, Meril was launched in line with the health-care diversification plan by a large format Indian multi-national company. Disclaimer: Information on Meril Digital / Social Media platform is not intended to be a substitute for professional medical advice, diagnosis or treatment. Meril does not recommend self-management of health issues. For more information, visit: https://www.merillife.com/disclaimer

Morepen Laboratories Limited is an Indian pharmaceutical company founded in 1984. It focuses on providing affordable and high-quality healthcare solutions through innovative pharmaceutical and medical technology products. The company is committed to excellence and aims to make health accessible worldwide. Morepen offers a diverse range of products, including high-quality Active Pharmaceutical Ingredients (APIs) such as Loratadine and Atorvastatin, as well as formulation products across various therapeutic categories like antibiotics and analgesics. The company also has a strong presence in the medical devices sector, particularly with its Blood Glucose and Blood Pressure Monitors. Morepen operates three manufacturing plants in Himachal Pradesh, India, and has a well-equipped R&D center that emphasizes innovation. With a robust distribution network of over 5,100 distributors and 328,000 retail touchpoints in India, Morepen exports its products to more than 50 countries, establishing itself as a significant player in the global generic drug market.

We are Nexstem. We create Brain-Computer Interface (BCI) solutions that help people interact with technology using their brain signals. Founded in 2020, by Siddhant and Deepansh - engineers with a passion for neuroscience and technology, we've been pushing the boundaries of what's possible in neurotech since our first product, the Nexstem V1 in 2022. At Nexstem, we specialize in non-invasive BCI devices, like our 19-channel headset, Instinct, which comes with a full software ecosystem to decode brain signals. Our goal is to make BCI technology accessible, empowering researchers, clinicians, and developers to innovate and explore new frontiers in brain-computer interaction. Nexstem's technology is recognised by many stalwarts of the industries includes Mircrosoft for Startups, NASSCOM, VIVA tech Paris, YourStory and many more. We have got support from some of the finest neuroscientists and doctors to build accessible tech for the neurotech. We strongly believe in creating value for people and NeuroTech Pulse is our monthly news letter that highlights a news round-up of neurotech industry across the globe, events, case studies and individual spotlights for notable achievers in the field. Do join us on substack - nexstem.substack.com

Prantae is the vision of what lies beyond the boundaries of human imagination. It is a leap-of-faith into 'tomorrow of connected technologies' that empowers each one of the human kind to take control his own health and well-being. It is the canvas of every creative scientist, engineer and doctor who desire to change the face of humanity for better wherever in the galaxy humans ever venture to

Reliance Life Sciences is a medical biotechnology-led company engaged in research and development, manufacturing and marketing of differentiated medical products and services, used to treat patients primarily in intensive and critical care units in hospitals. Our core businesses are plasma proteins, biosimilars, and later generation oncology pharmaceuticals. In addition, we have initiatives in clinical research, molecular medicine, regenerative medicine, gene therapy, peptides and oligonucleotides.

SciGen is a rapidly growing biopharmaceutical company that markets and commercializes innovative and affordable healthcare products worldwide. We leverage our commercialization and networking capabilities to in-licenses and distribute branded pharmaceutical products and medical devices to treat endocrinological and oncological diseases, and continuously fill and improve our pipeline and product portfolio. Founded in the Asian Innovation Capital, Singapore in 1988, we currently have operations in Singapore, South Korea, Australia, China, Philippines and present commercially in all 6 continents. With the exceptional commercialization capabilities, regulatory expertise as well as international management experiences, and strategic partnerships built with industry and academic institutes, we strive to deliver hope and make a real and lasting difference to patients and their families. Who are we? - We believe in delivering solutions that matter to the people of today and innovating for the people of tomorrow. - To us, it is more than a business - it is a mission. What do we do? - We combine a specialty pharmaceutical business with a leading biologics biotechnology engine. - We partner to bring the best drugs we can find to the patients who need it most. How do we do it? - Our efforts aim to deliver better patient outcomes through better science. - We understand that humility and service matter as it is not about us, it is about making patients’ lives better.

Stempeutics is a leading Regenerative Medicine company in Bangalore with our patented stem-cell therapy platform technology developing treatment of cardiovascular, immune-mediated and degenerative diseases. The company's flagship product, Stempeucel® has received market authorization to treat Critical Limb Ischemia – a major unmet medical need in India. It is the FIRST innovative cell therapy based product to get marketing approval in India and Globally. CIPLA, the Indian licensee, has commenced pan-India commercialization. It has the FIRST DCGI approved Cell therapy product for Knee Osteoarthritis being marketed by Alkem. Stempeutics has a product in the Phase 3 stage covering Diabetic Foot Ulcer. Further it is conducting Phase 2 trial in Perianal fistula due to Crohn’s disease. Stempeucel® has strong patent protection with 20 patents granted including US, Europe and Japan. Stempeucel® has been classified as an Advanced Therapy Medicinal Product (ATMP) and designated as an Orphan Drug for the treatment of CLI due to Buerger’s Disease by the European Medicines Agency (EMA) Another portfolio developed by Stempeutics is Stempeucare® range of cosmetics. It is developed from the stem cell derived Growth Factors/Cytokines combination for various cosmetic and derma applications including rejuvenation of aging skin, hair fall control & hair growth promotion, under eye dark circle reduction cream etc. First product which has gone to the market is an intensive firming skin care cosmetic product, branded as Cutisera™. Other products ready for marketing are Trichosera™ for Hair application and Optisera™ for under eye application With a strong pipeline in Cell and Gene therapy products in some of the largest health and personal care segments like OTC Cosmetics (Skin and Hair Care), Osteoarthritis, Diabetes, CLI and PAF Stempeutics is poised to transform the Cell & Gene therapy space with its India First, Global Next approach.

Since 1997, the journey of Trivitron Healthcare as a medical technology company providing affordable healthcare solutions has woven a fascinating thread of inspiration to many healthcare providers. Having solid expertise in research and development, Trivitron manufactures and distributes exceptional medical technology products to 180+ countries. With 15 certified manufacturing facilities in India, USA, Finland, Turkey & China; Trivitron spearheads innovation in the fields of In-Vitro Diagnostics, Imaging & Radiology, Radiation Protection, Newborn Screening, Critical Care & ICU Solutions and Renal Care Portfolio, thus, engraving its name as a holistic healthcare provider. 15 Manufacturing Facilities | Presence in 180+ Countries | 100,000+ Customer Base To learn more, visit www.trivitron.com

Vivo Bio Tech is a full service CRO offering drug development & discovery services to pharmaceutical & biotech companies world-wide in accordance with OECD, AAALAC & IND guidelines. The company offers services in the areas of custom research, In-vitro and In-vivo toxicity studies, pharmacological investigations, pharmacokinetics & toxicokinetic studies The company's state-of-the-art ‘preclinical research facility' spreads over 125,000 Sq.ft designed and built in compliance with Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC) and Good Laboratory Practice (GLP) guidelines. The facility is CPCSEA registered and AAALAC International accredited